ArticleNature medicine2009
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.
Leandro C Cerchietti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
93 papers cite itlatest 60 shown
this papertrialcites it